Search

Search Constraints

You searched for: Author/Creator Probert, Christopher

Search Results

1. IDDF2020-ABS-0183 PROFILE trial: predicting outcomes for Crohn's disease using a molecular biomarker. (18th November 2020)

2. Trial summary and protocol for a phase II randomised placebo-controlled double-blinded trial of Interleukin 1 blockade in Acute Severe Colitis: the IASO trial. Issue 2 (15th February 2019)

4. Patient preferences for treatment in steroid resistant ulcerative colitis – a discrete-choice experiment. (3rd July 2022)

5. Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study. (7th April 2022)

6. P201 Efficacy and safety of switching from intravenous to subcutaneous IFX (CT-P13): a multi-centre cohort study. (19th June 2022)

7. Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study. (February 2023)

8. Effectiveness and Safety of Vedolizumab (VDZ) in IBD Patients: A Multicenter Experience of "Real World Data" From the U.K.: 688. (October 2017)